Familial hypomagnesemia--hypercalciuria and pseudotumor cerebri
A Gregoric1, K Bracic, N Marcun-Varda
1Department of Pediatrics, Maribor Teaching Hospital, Maribor, Slovenia. pediatrija.mb@sb-mb.si
Insights
Familial hypomagnesemia-hypercalciuria can lead to serious complications. A child developed cerebral pseudotumor after thiazide treatment, suggesting a link between hypomagnesemia and intracranial pressure.
Area of Science:
- Pediatric Nephrology
- Neurology
- Medical Genetics
Background:
- Familial hypomagnesemia-hypercalciuria (FHH) is a rare genetic disorder characterized by renal wasting of magnesium and calcium.
- Key features include hypomagnesemia, hypercalciuria, renal insufficiency, and nephrocalcinosis.
- Treatment typically involves magnesium supplementation, thiazide diuretics, and potassium.
Observation:
- An 8-year-old girl with FHH presented with cardinal symptoms including hypomagnesemia, hypercalciuria, and renal insufficiency.
- She received combination therapy including magnesium salts, a thiazide diuretic, and potassium supplementation.
- After four years of treatment, she developed cerebral pseudotumor (idiopathic intracranial hypertension) with papilledema and visual field defects.
Findings:
- The cerebral pseudotumor resolved after discontinuation of the thiazide diuretic.
- Researchers hypothesize that prolonged thiazide-induced hypomagnesemia led to severe hypocalcemia, contributing to the pseudotumor.
- This is the first reported case of pseudotumor cerebri in a child with FHH secondary to thiazide therapy.
Implications:
- This case highlights a potential, previously unrecognized adverse effect of thiazide diuretics in patients with FHH.
- It underscores the importance of monitoring calcium and magnesium levels during long-term thiazide therapy, especially in pediatric patients with renal disorders.
- Further research is needed to elucidate the precise mechanism linking hypomagnesemia, hypocalcemia, and pseudotumor cerebri in this context.
Abstract:
Approximately 30 patients with familial hypomagnesemia-hypercalciuria have been reported. We describe an 8-year-old girl with cardinal findings of familial hypomagnesemia-hypercalciuria (hypomagnesemia, hypermagnesiuria, hypercalciuria, renal insufficiency, hyperuricemia, elevated serum parathormone, hyposthenuria and nephrocalcinosis), who received combination therapy consisting of magnesium salts, thiazide diuretic and potassium supplementation. At the 4-year follow-up investigation under this treatment, the patient was found to have cerebral pseudotumor (increased intracranial pressure with normal or small ventricles on neuroimaging, no evidence of an intracranial mass and normal cerebrospinal fluid composition) with papilledema and visual field defects. Thiazide therapy was terminated and the cerebral pseudotumor disappeared. The authors hypothesize that cerebral pseudotumor in this patient was related to severe hypocalcemia, as a consequence of profound hypomagnesemia induced by protracted thiazide treatment. To our knowledge, this is the first report of a child with familial hypomagnesemia-hypercalciuria who developed pseudotumor cerebri after thiazide therapy.
Related Concept Videos
Huntington Disease l: Introduction
Lysosomal Hydrolases
Hepatic Encephalopathy
Microtubules in Signaling
Alterations in Muscle Tone lll
Skeleton and Calcium Homeostasis

